HADCORP

Home

Implant Research

Dr Ostermeyer's Research

Neoplasms & Implants

Platinum Testing

Children and Silicone

About Breast Implants

Alternative Implants

Suicide and Implants

Implants and the FDA

Implants in the UK

Silicone Immune Protocol

Biotoxins

MCS

Implant Identification

Implant Photos

Orthopaedic Implants

Board of Directors

Medical Device News

Glossary

Implant Resources

Contact Us

Members
 

Knowledge Empowers   


Tumori. 2007 Sep-Oct;93(5):504-7.

Malignant fibrous histiocytoma associated with coxofemoral arthrodesis.

Olmedo DG, Michanié E, Oivi L, Santini-Araujo E, Cabrini RL.

Department of Oral Pathology, School of Dentistry, University of Buenos Aires, Buenos Aires, Argentina. dolmedo@argentina.com

The discovery of biomaterials led to their use in the manufacture of implants for biomedical applications. In vivo, no metal or alloy is completely inert. The potential toxicity of some of the metals most frequently employed in the manufacture of orthopedic implants has been reported. Their carcinogenic potential has been evaluated in experimental animal models. However, few reports have discussed the potential development of malignant tumors associated with prosthetic structures in humans. The present study documents a case of intraosseous sarcoma that developed in the vicinity of a metallic prosthesis 43 months after a coxofemoral arthrodesis with metallic pins and screws. With this report the authors seek to contribute to the understanding of the potential toxicity and risks of using metallic implants. Since metallic implants employed in the rehabilitation of osteo-muscular-articular disorders usually remain in the organism for long periods of time, the need to monitor the metallic structures and the adjacent tissues is extremely relevant.

PMID: 18038887 [PubMed - indexed for MEDLINE]

 

<<Back

The information on this site is presented for educational purposes by Hadcorp.